News Release

Mallinckrodt plc Announces Annual Shareholder Meeting Date

DUBLIN--(BUSINESS WIRE)--Nov. 21, 2013-- Mallinckrodt plc (NYSE: MNK) today announced that its Board of Directors has set Thursday, March 20, 2014 as the date for its annual general meeting of shareholders. The meeting will be held at 3:00 pm, local time at the Conrad Hilton Hotel, Earlsfort Terrace, Dublin 2, Ireland. Shareholders of record at the close of business on January 10, 2014, are entitled to receive notice of the meeting and will be eligible to vote.

About Mallinckrodt

Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s Specialty Pharmaceuticals segment includes branded and generic drugs and active pharmaceutical ingredients, and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has approximately 5,500 employees worldwide and commercial presence in roughly 70 countries. The company’s 2013 revenue totalled $2.2 billion. To learn more about Mallinckrodt, visit

Source: Mallinckrodt

Lynn Phillips, 314-654-3263
Manager, Media Relations
John Moten, 314-654-6650
Vice President, Investor Relations